healthcare-thumbnail.png

Medical Imaging PACS & VNA Market Research Report –Segmentation by Component (Software, Services, Others); by Deployment Mode (On-Premises, Cloud-Based, Hybrid, Others; by Imaging Modality (Radiology, Cardiology, Oncology, Orthopedics, Mammography, Others); by End User (Hospitals, Diagnostic Imaging Centers, Specialty Clinics, Academic & Research Institutes, Others) ; and Region - Size, Share, Growth Analysis | Forecast (2026– 2030)

Global Medical Imaging PACS & VNA Market Size (2026-2030)

In 2025, the Medical Imaging PACS & VNA Market was valued at approximately USD 4.85 Billion. It is projected to grow at a CAGR of around 11.9% during the forecast period of 2026–2030, reaching an estimated USD 8.51 Billion by 2030.

The Global Medical Imaging PACS & VNA Market includes technologies and solutions to store, manage, retrieve, distribute, and archive medical images in healthcare settings. Picture Archiving and Communication Systems are used to support clinical imaging workflows, and Vendor Neutral Archives are used to store and share images for the long term across multiple systems. It includes the platforms, supporting infrastructure, implementation and migration, maintenance, and workflow management. It does not include imaging equipment (MRI, CT), other hospital information management systems, and non-clinical data storage systems used for non-imaging purposes.

The market has evolved from departmental-based image storage to enterprise imaging approaches. Patients, clinicians, and administrators now seek easy access to images across radiology, cardiology, oncology, orthopedics, and other specialties across multiple sites. The move to the cloud has gathered pace as companies look for flexibility, enhanced disaster recovery, and lower costs with improved predictability, though hybrid deployments are still common when latency issues, regulatory considerations, or legacy systems are involved. Meanwhile, security, governance, and vendor lock-in risks have climbed the corporate ladder, from IT to the boardroom, as concerns over cybersecurity, data sovereignty, and the complexities of multi-vendor integration increase.

This market has evolved for decision-makers from IT products to strategic infrastructure. Customers are considering migration and interoperability needs, availability, and future archive control in the context of purchase price. Health care providers are seeking solutions that can consolidate multiple image archives and accommodate growth. Imaging vendors offering flexible deployment options, deep integration, and workflow improvements are best positioned to meet demand as healthcare systems upgrade their imaging infrastructure.

Key Market Insights

  • AI spending in healthcare grew 67%, driving growth in imaging workflow automation.
  • 20% lower cloud infrastructure costs made PACS upgrades more attractive.
  • Generative AI trials at 70% providers support imaging productivity strategies.
  • Data interoperability needs grew 52%, boosting VNA replacement interest worldwide.
  • Cybersecurity costs 1.9x more to healthcare firms.
  • A 16% growth in Asia Pacific's digital health investments boosted imaging.
  • Cloud-first approaches to core systems are favored by 75% of executives.
  • Workflow automation reduced administrative costs by 30%, helping radiology.
  • Hybrid cloud usage was over 60%, aiding archive migration.
  • AI-based diagnosis boosted productivity 25% in trials.
  • Asia has higher growth than the North American market.
  • Data will be modernized in two years, 80% of leaders say.

Research Methodology

Scope & definitions

  • Covers operating revenue from medical imaging PACS and vendor neutral archive (VNA) software, hardware, and related implementation/support tied to image management workflows.
  • Excludes unrelated EHR modules, standalone imaging devices, and non-clinical IT spend.
  • Geography: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa; historical base, current year estimate, and forecast period defined in-report.
  • Segmentation follows component, deployment mode, imaging modality, end user, and region.
  • Standardized data dictionary, currency normalization, and supplier mapping prevent overlap/double counting.

Evidence collection (primary + secondary)

  • Primary research across OEMs, PACS/VNA vendors, cloud providers, distributors, hospital IT leaders, radiology administrators, imaging centers, and channel partners.
  • Interviews validate pricing, adoption, replacement cycles, procurement models, and demand outlook.
  • Secondary sources include audited filings, investor presentations, company websites, procurement databases, peer-reviewed journals, OECD, WHO, FDA, European Commission, HIMSS, RSNA, and relevant regulators/standards bodies/industry associations specific to Global Medical Imaging PACS & VNA Market (named in-report).
  • Key claims are supported with verifiable, source-linked evidence in-report.

Triangulation & validation

  • Bottom-up sizing from vendor revenues, installed base, contracts, and ASPs.
  • Top-down sizing from healthcare IT, imaging informatics, and regional spend benchmarks.
  • Results reconciled to financial disclosures where applicable.
  • Conflicting sources resolved through recency, methodology quality, and multi-source consensus controls.

Presentation & auditability

  • All assumptions, formulas, sources, and revisions logged.
  • Segment totals reconcile to 100%; CAGR and forecast models are traceable and review-ready.

Global Medical Imaging PACS & VNA Market Drivers

Increasing need for interoperable enterprise imaging environments across systems

Interoperable imaging ecosystems that link radiology, cardiology, oncology, and other imaging modalities into a common data model are a growing priority for healthcare providers. This is in response to the need to streamline disjointed systems of storage and access to diagnostic images. Picture archiving and communication systems (PACS) and vendor-neutral archives (VNA) are increasingly vital components of enterprise imaging strategies, facilitating the sharing of data between hospitals, diagnostic imaging facilities, and specialty clinics.

Speedy move to cloud and hybrid imaging infrastructure

Healthcare providers are increasingly shifting from on-premises to cloud-based and hybrid imaging infrastructure models for scalability, flexibility, and accessibility. The shift is being driven by the growth in imaging data, growing storage needs, and requirements for clinical disaster preparedness. PACS and VNA systems hosted on the cloud facilitate rapid access to images, image management, and fewer infrastructure demands on hospitals.

Increasing demands for cost efficiency and system upgrades

Hospitals are constantly challenged to replace legacy imaging systems while keeping costs under control and avoiding vendor lock-in. Inefficiencies in managing data migration, integration, and scalability of storage in legacy PACS systems drive the need for integrated PACS and VNA systems. This eliminates data duplication, simplifies management, and enhances data lifecycle management.

Global Medical Imaging PACS & VNA Market Restraints

Constraints and challenges in the global medical imaging PACS & VNA market include increasing integration complexities, legacy system lock-ins, and the increasing cost of data migration in multi-site imaging environments. Healthcare providers face challenges integrating legacy and new systems, which delay transition to integrated imaging systems. Growing cloud-based deployments create cybersecurity threats, requiring more security controls.

Global Medical Imaging PACS & VNA Market Opportunities

Market opportunities in the global medical imaging PACS & VNA market are growing as providers ramp up their cloud adoption, imaging platform consolidation, and integration upgrades in multi-site environments. Suppliers can leverage the burgeoning need for AI-powered imaging operations, particularly in radiology and oncology, with increasing diagnostic loads.

How this market works end-to-end

  1. Image is created

Modalities such as radiology, cardiology, oncology, orthopedics, and mammography generate studies that need routing and storage.

  1. Data is ingested

PACS captures the study, applies workflow rules, and makes the image immediately available to clinicians.

  1. Access is coordinated

Authorized users view, compare, and report on images across departments, sites, and sometimes external referral networks.

  1. Archive is governed

VNA provides long-term, vendor-neutral retention so records can be preserved across system changes and migrations.

  1. Systems are integrated

PACS and VNA connect with RIS, EMR, identity systems, cybersecurity tools, and analytics layers.

  1. Deployment is chosen

Buyers decide between on-premise, cloud-based, or hybrid models based on control, latency, compliance, and cost.

  1. Ownership is scaled

Hospitals, diagnostic imaging centers, specialty clinics, and academic users prioritize different uptime, storage, and governance needs.

  1. Region shapes design

North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa differ on regulation, cloud readiness, and procurement pace.

Why this market matters now

The market is being shaped by a simple tension: clinical teams need faster access to images, while IT teams need tighter control over cost, security, and data portability. That tension makes PACS and VNA decisions more strategic than routine software buys.

A weak architecture can lock a buyer into a slow migration path, limit interoperability, and create hidden retention costs. A strong one can reduce switching risk, support multi-site expansion, and make future cloud adoption less disruptive. The real issue is not whether imaging systems exist today. It is whether they can still work cleanly when volume rises, cyber rules tighten, or a vendor strategy changes.

What matters most when evaluating claims in this market

Claim type

What good proof looks like

What often goes wrong

Market size

Clear boundary, defined revenue pool, consistent segment logic

Mixing software, hardware, and unrelated IT spend

Cloud adoption

Named deployment scope and buyer use case

Treating pilot interest as full-scale conversion

Interoperability

Documented integrations and workflow evidence

Counting compatibility claims as live deployments

Vendor leadership

Comparable revenue basis and region coverage

Using brand visibility instead of measurable share

Migration success

Verified installs, go-live evidence, and retention outcomes

Confusing announced deals with operating revenue

The decision lens

  1. Set the boundary

Confirm whether the need is PACS, VNA, or both, and whether the buying unit is software-only or bundled infrastructure.

  1. Map the workflow

Trace how images move from modality to archive to viewer, then identify where delays, duplications, or manual work appear.

  1. Test deployment fit

Compare on-premise, cloud, and hybrid options against latency, control, compliance, and internal IT capacity.

  1. Check integration depth

Verify links to EMR, RIS, identity, security, and reporting tools, not just marketing claims.

  1. Stress migration risk

Ask how data will move, who owns the archive, what downtime is acceptable, and how rollback is handled.

  1. Price the full path

Compare license, implementation, maintenance, storage, training, support, and exit costs, not just entry pricing.

The contrarian view

The biggest mistake is treating PACS and VNA as a single uniform market. They solve different problems, and buyers often need both for different reasons. Another common error is using deployment labels as a proxy for readiness. A cloud logo does not prove operational fit, and an on-premise system does not prove resilience. The third mistake is hidden double counting, especially when vendors package storage, services, and software together. Good analysis must separate operating revenue from implementation noise and avoid counting the same workflow twice across modalities or end users.

Practical implications by stakeholder

Hospital CIO and IT leader

  • Needs architecture that reduces lock-in without creating new migration risk.
  • Must weigh uptime, security, and integration cost together.
  • Should challenge any claim that ignores exit planning.

Radiology leadership

  • Needs fast image access, stable reporting, and minimal workflow friction.
  • Should compare modality-specific fit, not just enterprise branding.
  • Must assess whether the vendor supports multi-site consistency.

Imaging center operator

  • Needs predictable costs, quick deployment, and reliable sharing with referrers.
  • Should favor simple workflows over complex feature bundles.
  • Must test whether support is strong enough for lean IT teams.

Cybersecurity and compliance teams

  • Needs proof of access control, auditability, backup, and retention governance.
  • Should examine data movement, user authentication, and incident response.
  • Must verify how regional rules affect hosting and archiving.

Vendors and partners

  • Must prove interoperability, not just feature depth.
  • Need clear segmentation by component, deployment, modality, end user, and geography.
  • Should address migration economics and data ownership early.

ROBOTICS MARKET REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2025 - 2030

Base Year

2025

Forecast Period

2026 - 2030

CAGR

11.9%

Segments Covered

By component, Deployment Mode Imaging Modality  , End User , and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regional Scope

North America, Europe, APAC, Latin America, Middle East & Africa

Key Companies Profiled

GE HealthCare, Philips Healthcare, Siemens Healthineers, Fujifilm Holdings Corporation, Agfa-Gevaert Group, Sectra AB, Merge Healthcare, Intelerad Medical Systems, Carestream Health, Konica Minolta, Inc., Canon Medical Systems Corporation, Dedalus Group, Hyland Software, Inc., INFINITT Healthcare Co., Ltd., and Novarad Corporation

Global Medical Imaging PACS & VNA Market Segmentation

Global Medical Imaging PACS & VNA Market – By Component


• Introduction/Key Findings
• Software
• Hardware
• Services
• Others
• Y-O-Y Growth Trend & Opportunity Analysis

Software is the leading component segment by share at 68.4% in 2026, with enterprise PACS, VNA archives, and sophisticated image viewing software. Suppliers preferred flexible licenses and subscriptions to enhance workflow efficiency, interoperability, and access to images over networks around the world.

Services are the fastest-growing component, growing at an 11.9% CAGR to 2030, driven by increased migration, security, integration, and managed services. Use of outsourced upgrades and archive migrations grows to limit disruption, risk, and staffing demands on the health system.

Global Medical Imaging PACS & VNA Market – By Deployment Mode


• Introduction/Key Findings
• On-Premise
• Cloud-Based
• Hybrid
• Others
• Y-O-Y Growth Trend & Opportunity Analysis

On-Premises was the largest deployment mode segment, with a 46.8% share in 2026, as hospitals maintain control and low-latency access to infrastructure while ensuring data integrity. Existing installed bases and integration needs sustained replacement and upgrades globally.

Cloud-based is the highest-growing deployment mode with a CAGR of 14.6% by 2030. Customers prefer scalability, reduced capital expenditures, remote access, and superior disaster recovery to upgrade enterprise imaging environments cost-effectively globally.

Global Medical Imaging PACS & VNA Market – By Imaging Modality


• Introduction/Key Findings
• Radiology
• Cardiology
• Oncology
• Orthopedics
• Mammography
• Others
• Y-O-Y Growth Trend & Opportunity Analysis

Global Medical Imaging PACS & VNA Market – By End User


• Introduction/Key Findings
• Hospitals
• Diagnostic Imaging Centers
• Specialty Clinics
• Academic & Research Institutes
• Others
• Y-O-Y Growth Trend & Opportunity Analysis

Global Medical Imaging PACS & VNA Market Regional Analysis

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

North America remained the largest region with 39.0% share in 2026 due to established imaging networks, healthy healthcare IT spending, and replacement cycles. Cybersecurity, interoperability, and enterprise archive modernization were preferred by large hospitals for integrated care systems.

The Asia-Pacific region is the fastest-growing, with a 13.7% CAGR to 2030. Increasing diagnostic procedures, hospital construction, and fast-growing cloud computing in China, India, Japan, and Southeast Asia are fueling growth in imaging systems.

Latest Market News

Mar 18, 2026: GE HealthCare said it has closed the Intelerad deal, paying a base price of $2.3 billion to acquire a company that will add some $270 million in first full-year revenue. Further, it said 90% of Intelerad revenue is recurring, reflecting the trend to cloud-based imaging software.

Feb 21, 2026: News on PACS software showed that a CT study may consist of over 1,000 images, and busy radiology clinics may handle hundreds of studies per day. The take-home message was that scalability and speed of archives and workflows are IT priorities for boards.

On Nov 20, 2025, GE HealthCare said it would pay $2.3 billion in cash for Intelerad with the plan to close in the first half of 2026, subject to approvals. The company stated that the acquisition helps it to triple cloud offerings by 2028.

On Nov 20, 2025, GE HealthCare released that Intelerad should bring in about $270 million in revenue in the first 12 months post-closing with EBITDA margins exceeding 30%. For PACS and VNA customers, this is a sign of increased strategic importance of recurring SaaS imaging.

May 15, 2025: Revised forecasts for the industry noted the market's 2024 installed revenue base of around $4.62 billion and 2025 forecast of $5.10 billion, due to continued replacement and migration to the cloud. Buyer commentary focused on interoperability, analytics, and modernizing archives.

Jun 11, 2024 New market analysis noted multiple-site VNA deployments were expected to be the fastest-growing architecture through 2029, with on-premises deployments remaining the leading architecture in 2023. The study mapped over 400 pages of vendor and geographic intelligence, shining a spotlight on the buyer interest in enterprise imaging strategy.

May 30, 2024 A competitive review tracked procurement of enterprise PACS and VNA and deployments, including on-premise, cloud, and hybrid, to 2031. The research focused on modality needs (CT, MRI, ultrasound) for 3+ imaging segments.

Key Players

  1. GE HealthCare
  2. Philips Healthcare
  3. Siemens Healthineers
  4. Fujifilm Holdings Corporation
  5. Agfa-Gevaert Group
  6. Sectra AB
  7. Merge Healthcare
  8. Intelerad Medical Systems
  9. Carestream Health
  10. Konica Minolta, Inc.

Questions buyers ask before purchasing this report

What is the real scope of the Global Medical Imaging PACS & VNA Market?

This report focuses on the revenue pool tied to PACS and VNA use in imaging workflows. It separates core software and related infrastructure from broader hospital IT, imaging devices, and unrelated clinical software. That matters because buyers often compare reports that use different boundary rules. A clean scope lets decision-makers see what is really driving spend, what is bundled, and where double counting can distort the size of the market.

Does the report cover both PACS and VNA in a usable way?

Yes, and that distinction is critical. PACS is about daily image access and clinical workflow, while VNA is about long-term, vendor-neutral retention and portability. Many buyers need both, but not for the same reason. A strong report should show how these systems interact, where they overlap, and where the economics differ. That is what helps teams decide whether they need refresh, replacement, expansion, or a hybrid transition.

How does the report help with cloud versus on-premise decisions?

It should help buyers compare deployment models against real operating constraints. Cloud may improve flexibility, but it also changes control, cost structure, integration design, and migration risk. On-premise can preserve direct control, but it may increase maintenance burden. Hybrid is often the practical middle path. A useful report should show which deployment choices fit which buyer type, rather than treating cloud adoption as a universal endpoint.

Why is segmentation important in this market?

Segmentation changes the answer. A hospital group, imaging center, and specialty clinic do not buy PACS and VNA the same way. Neither do radiology and cardiology workflows. Geography also matters because procurement pace, cloud acceptance, and compliance pressure vary by region. A report that segments by component, deployment mode, imaging modality, end user, and geography helps buyers compare like with like and avoid broad averages that hide real differences.

What kinds of risks should a buyer expect this report to clarify?

The most important risks are vendor lock-in, migration disruption, cyber exposure, hidden integration cost, and underestimated storage or retention obligations. Buyers also need to see where growth assumptions may be overstated by bundled offerings or loose market definitions. A good report should help teams stress-test timing, compare suppliers, and understand whether a purchase is solving a real operational problem or simply delaying a larger one.

How does this report support a purchase decision under budget pressure?

It should show where spend creates operational value and where it does not. That means separating must-have workflow stability from optional features, comparing deployment paths, and identifying which segment is truly under pressure to replace legacy systems. In a budget-constrained environment, the right question is not just what the market is worth. It is which buying choice reduces risk, protects continuity, and improves image access without adding hidden future cost.

 


 
Chapter 1. MEDICAL IMAGING PACS & VNA MARKET  – SCOPE & METHODOLOGY
   1.1. Market Segmentation
   1.2. Scope, Assumptions & Limitations
   1.3. Research Methodology
   1.4. Primary Source
   1.5. Secondary Source
 Chapter 2. MEDICAL IMAGING PACS & VNA MARKET  – EXECUTIVE SUMMARY
  2.1. Market Size & Forecast – (2026 – 2030) ($M/$Bn)
  2.2. Key Trends & Insights
              2.2.1. Demand Side  
              2.2.2. Supply Side     
   2.3. Attractive Investment Propositions
   2.4. COVID-19 Impact Analysis
 Chapter 3. MEDICAL IMAGING PACS & VNA MARKET  – COMPETITION SCENARIO
   3.1. Market Share Analysis & Company Benchmarking
   3.2. Competitive Strategy &  Packaging COMPONENT Scenario
   3.3. Competitive Pricing Analysis
   3.4. Supplier-Distributor Analysis
 Chapter 4. MEDICAL IMAGING PACS & VNA MARKET  - ENTRY SCENARIO
4.1. Regulatory Scenario
4.2. Case Studies – Key Start-ups
4.3. Customer Analysis
4.4. PESTLE Analysis
4.5. Porters Five Force Model
               4.5.1. Bargaining Power of Suppliers
               4.5.2. Bargaining Powers of Customers
               4.5.3. Threat of New Entrants
               4.5.4. Rivalry among Existing Players
               4.5.5. Threat of Substitutes Players
                4.5.6. Threat of Substitutes
 Chapter 5. MEDICAL IMAGING PACS & VNA MARKET  - LANDSCAPE
   5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
   5.2. Market Drivers
   5.3. Market Restraints/Challenges
   5.4. Market Opportunities    
Chapter 6. MEDICAL IMAGING PACS & VNA MARKET  – By   Component 
6.1    Introduction/Key Findings   
6.2    Software
6.3    Hardware
6.4    Services
6.5    Others 
6.6    Y-O-Y Growth trend Analysis By Component 
6.7    Absolute $ Opportunity Analysis By Component , 2026-2030
 
Chapter 7. MEDICAL IMAGING PACS & VNA MARKET  – By  Deployment Mode 
7.1    Introduction/Key Findings   
7.2    On-Premise
7.3     Cloud-Based
7.4    Hybrid
7.5    Others 
7.6    Y-O-Y Growth  trend Analysis By  Deployment Mode 
7.7    Absolute $ Opportunity Analysis By  Deployment Mode, 2026-2030
 
Chapter 8.  MEDICAL IMAGING PACS & VNA MARKET – By Imaging Modality
8.1    Introduction/Key Findings   
8.2    Radiology
8.3     Cardiology
8.4    Oncology
8.5     Orthopedics
8.6     Mammography
8.7     Others

8.8    Y-O-Y Growth trend Analysis Imaging Modality
8.9    Absolute $ Opportunity Analysis Imaging Modality, 2026-2030
Chapter 9.  MEDICAL IMAGING PACS & VNA MARKET – By End User 
9.1    Introduction/Key Findings   
9.2     Hospitals
9.3     Diagnostic Imaging Centers
9.4     Specialty Clinics
9.5     Academic & Research Institutes
9.6     Others

9.7    Y-O-Y Growth trend Analysis End User 
9.8    Absolute $ Opportunity Analysis, End User 2026-2030
 
Chapter 10.  MEDICAL IMAGING PACS & VNA MARKET , By Geography – Market Size, Forecast, Trends & Insights
10.1. North America
                                10.1.1. By Country
                                                10.1.1.1. U.S.A.
                                                10.1.1.2. Canada
                                                10.1.1.3. Mexico
                                10.1.2. By   Component 
                                10.1.3. By  End User 
                                10.1.4. By Imaging Modality
                                10.1.5. Deployment Mode 
                                10.1.6. Countries & Segments - Market Attractiveness Analysis
   10.2. Europe
                                10.2.1. By Country
                                                10.2.1.1. U.K.                         
                                                10.2.1.2. Germany
                                                10.2.1.3. France
                                                10.2.1.4. Italy
                                                10.2.1.5. Spain
                                                10.2.1.6. Rest of Europe
                                10.2.2. By   Component 
                                10.2.3. By   End User 
                                10.2.4. By Imaging Modality
                                10.2.5. Deployment Mode 
                                10.2.6. Countries & Segments - Market Attractiveness Analysis
10.3. Asia Pacific
                                10.3.1. By Country
                                                10.3.1.2. China
                                                10.3.1.2. Japan
                                                10.3.1.3. South Korea
                                                10.3.1.4. India      
                                                10.3.1.5. Australia & New Zealand
                                                10.3.1.6. Rest of Asia-Pacific
                                10.3.2. By  Component 
                                10.3.3. By  Deployment Mode 
                                10.3.4. By Imaging Modality
                                10.3.5. End User 
                                10.3.6. Countries & Segments - Market Attractiveness Analysis
10.4. South America
                                10.4.1. By Country
                                                10.4.1.1. Brazil
                                                10.4.1.2. Argentina
                                                10.4.1.3. Colombia
                                                10.4.1.4. Chile
                                                10.4.1.5. Rest of South America
                                10.4.2. By   Deployment Mode 
                                10.4.3. By  Component 
                                10.4.4. By End User 
                                10.4.5. Imaging Modality
                                10.4.6. Countries & Segments - Market Attractiveness Analysis
10.5. Middle East & Africa
                                10.5.1. By Country
                                                10.5.1.4. United Arab Emirates (UAE)
                                                10.5.1.2. Saudi Arabia
                                                10.5.1.3. Qatar
                                                10.5.1.4. Israel
                                                10.5.1.5. South Africa
                                                10.5.1.6. Nigeria
                                                10.5.1.7. Kenya
                                                10.5.1.10. Egypt
                                                10.5.1.10. Rest of MEA
                                10.5.2. By  Deployment Mode 
                                10.5.3. By  Component  
                                10.5.4. By Imaging Modality
                                10.5.5. End User 
                                10.5.6. Countries & Segments - Market Attractiveness Analysis
Chapter 11.  MEDICAL IMAGING PACS & VNA MARKET  – Company Profiles – (Overview, Portfolio, Financials, Strategies & Developments)
11.1    GE HealthCare
11.2    Philips Healthcare
11.3    Siemens Healthineers
11.4    Fujifilm Holdings Corporation
11.5    Agfa-Gevaert Group
11.6    Sectra AB
11.7    Merge Healthcare
11.8    Intelerad Medical Systems
11.9    Carestream Health
11.10    Konica Minolta, Inc.

Download Sample

The field with (*) is required.

Choose License Type

$

2500

$

4250

$

5250

$

6900

Frequently Asked Questions

In 2025, the Medical Imaging PACS & VNA Market was valued at approximately USD 4.85 Billion. It is projected to grow at a CAGR of around 11.9% during the forecast period of 2026–2030, reaching an estimated USD 8.51 Billion by 2030.

The major drivers of the Global Medical Imaging PACS & VNA Market include the increasing need for interoperable enterprise imaging environments across healthcare systems, the rapid shift toward cloud-based and hybrid imaging infrastructure, and rising demand for scalable image storage and disaster recovery solutions. Growth is further supported by increasing imaging volumes, modernization of legacy PACS systems, stronger focus on workflow efficiency, and growing concerns around cybersecurity, data sovereignty, and vendor lock-in. In addition, healthcare providers are prioritizing multi-site image accessibility, archive consolidation, and AI-enabled imaging workflows, which continue to accelerate market expansion globally.

Software, Services, and Others are the segments under the Global Medical Imaging PACS & VNA Market by Component. On-Premises, Cloud-Based, Hybrid, and Others are the segments by Deployment Mode. Radiology, Cardiology, Oncology, Orthopedics, Mammography, and Others are the segments by Imaging Modality. Hospitals, Diagnostic Imaging Centers, Specialty Clinics, Academic & Research Institutes, and Others are the segments by End User.

North America is the most dominant region for the Global Medical Imaging PACS & VNA Market, holding approximately 39% share. This leadership is driven by advanced healthcare IT infrastructure, established imaging networks, strong replacement demand, and rising investments in enterprise archive modernization. Asia Pacific holds the fastest growth outlook due to expanding hospital infrastructure, rising imaging volumes, rapid cloud adoption, and increasing healthcare digitization across emerging economies. Europe accounts for a significant share supported by mature healthcare systems, while Latin America and the Middle East & Africa continue to gain traction through ongoing healthcare modernization initiatives.

The key players in the Global Medical Imaging PACS & VNA Market include GE HealthCare, Philips Healthcare, Siemens Healthineers, Fujifilm Holdings Corporation, Agfa-Gevaert Group, Sectra AB, Merge Healthcare, Intelerad Medical Systems, Carestream Health, Konica Minolta, Inc., Canon Medical Systems Corporation, Dedalus Group, Hyland Software, Inc., INFINITT Healthcare Co., Ltd., and Novarad Corporation.

Analyst Support

Every order comes with Analyst Support.

Customization

We offer customization to cater your needs to fullest.

Verified Analysis

We value integrity, quality and authenticity the most.